Literature DB >> 3699408

Urinary excretion of polyethylene glycol 3350 and sulfate after gut lavage with a polyethylene glycol electrolyte lavage solution.

C E Brady, J A DiPalma, S G Morawski, C A Santa Ana, J S Fordtran.   

Abstract

Ingestion of an electrolyte lavage solution containing polyethylene glycol 3350 and sulfate is an effective method of cleansing the colon for diagnostic studies. Polyethylene glycol and sulfate are considered poorly absorbed from the gastrointestinal tract. Because of the quantities administered, concern exists about potential toxicity of absorption of even a small percentage, particularly for polyethylene glycol. We measured the urinary excretion of both polyethylene glycol and sulfate in normal subjects and inflammatory bowel patients. Absorption of polyethylene glycol can be assessed by measuring recovery in urine, as 85%-96% of an intravenous load is excreted in urine. Similarly, appreciable sulfate absorption would exceed renal tubular reabsorption and result in increased urinary excretion. Mean percent polyethylene glycol load recovered in urine was minimal and similar for normal (0.06%) and inflammatory bowel (0.09%) subjects. Urinary sulfate excretion after lavage was also similar for both groups and was not different from baseline. These results do not suggest the likelihood of toxicity due to polyethylene glycol 3350 or sulfate absorption during gut lavage with this solution.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3699408     DOI: 10.1016/0016-5085(86)90261-1

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  23 in total

1.  Update on preparation for colonoscopy.

Authors:  Stephen W Landreneau; Jack A Di Palma
Journal:  Curr Gastroenterol Rep       Date:  2010-10

2.  Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation.

Authors:  A Attar; M Lémann; A Ferguson; M Halphen; M C Boutron; B Flourié; E Alix; M Salmeron; F Guillemot; S Chaussade; A M Ménard; J Moreau; G Naudin; M Barthet
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

3.  Intestinal effects of sulfate in drinking water on normal human subjects.

Authors:  W D Heizer; R S Sandler; E Seal; S C Murray; M G Busby; B G Schliebe; S N Pusek
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

Review 4.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

5.  Sudden death in Whipple's disease.

Authors:  P McGettigan; E E Mooney; M Sinnott; E C Sweeney; J Feely
Journal:  Postgrad Med J       Date:  1997-08       Impact factor: 2.401

6.  Effect of concomitant polyethylene glycol and celecoxib on colonic aberrant crypt foci and tumors in F344 rats.

Authors:  Khoa Do; Graham F Barnard
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

Review 7.  Whole bowel irrigation as a gastrointestinal decontamination procedure after acute poisoning.

Authors:  M Tenenbein
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr

8.  Small volume isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in treatment of chronic nonorganic constipation.

Authors:  E Corazziari; D Badiali; F I Habib; G Reboa; G Pitto; G Mazzacca; F Sabbatini; R Galeazzi; T Cilluffo; I Vantini; E Bardelli; F Baldi
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

9.  PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial.

Authors:  W Voskuijl; F de Lorijn; W Verwijs; P Hogeman; J Heijmans; W Mäkel; J Taminiau; M Benninga
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

Review 10.  Bowel preparation for gastrointestinal procedures.

Authors:  Andrew R Brown; Jack A DiPalma
Journal:  Curr Gastroenterol Rep       Date:  2004-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.